Planning and Evaluation Core for a cancer center partnership
Official title: Core 1: Planning and Evaluation
Funded at Beckman Research Institute/city of Hope · NIH-11415821 · Data updated 2026-11-12
A planning and evaluation core helps a California cancer center partnership track progress, share lessons, and strengthen education and collaboration for better cancer research and drug development.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $81,566 |
| NIH project number | 5U54CA285116-04 |
| Project ID | NIH-11415821 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not a patient-facing trial; focuses on program planning and evaluation to support cancer research and education across institutions.
✕Less likely to help
Participants will not be enrolled as patients in this core; no direct patient procedures are described.
What this research studies
This grant supports a coordinated planning and evaluation core that monitors milestones, tracks progress, and guides capacity building for a joint UCR-CoHCCC cancer research partnership. It involves structured review processes with advisory boards to select projects, pilot efforts, and training activities. The core aims to enhance translational resources, education, and cross-institutional collaboration across the cancer drug development pipeline. The focus is on harnessing data and feedback to improve outcomes and ensure accountability within the partnership.
Why it matters
Potential benefit: If successful, the partnership could accelerate cancer research and training, leading to stronger collaboration and more efficient drug development.
How similar studies have gone: Prior planning grants and mixed-model partnerships have shown that structured evaluation improves alignment and productivity in cancer research programs.
Where this research is happening
-
Beckman Research Institute/city of Hope
Duarte, United States Active
Researchers
- Principal investigator: Ann, David K. — Beckman Research Institute/city of Hope
- Study coordinator: Ann, David K.
Related research
Other NIH-funded projects on the same topics.
-
Targeting the protein-assembly that drives AML growth
Aiming to slow or stop acute myeloid leukemia by blocking how cancer cells make proteins.
-
Metformin for reversing accelerated aging in young adults with metabolic health issues
A practical plan to use metformin to help 18- to 35-year-olds with insulin resistance improve metabolic health and slow aging.
-
PIN1-targeted therapy for pancreatic cancer
A team is developing new PIN1 inhibitors to treat pancreatic cancer that tends to resist current therapies.
-
DNA mismatch repair defects and anti-tumor immunity in cancer
Researchers are studying how defects in a DNA repair system affect the body’s immune response to tumors, to improve cancer treatments that use the immune system.
-
Understanding how skin cancer-associated fibroblasts affect immune detection in early mycosis fungoides
This grant investigates how certain skin cells in early mycosis fungoides might help the cancer hide from the immune system, with findings aiming to improve future patient care.
-
Small-molecule and biologic treatments for glioblastoma using targeted brain delivery
A new approach aims to use FPS-ZM1 to shrink brain swelling and support immunotherapy for glioblastoma, potentially helping patients recover after surgery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.